In MS, astrocytes respond to IL17 and IL6 released by T cells and release large amounts of CCL5, which binds to CCR5 to control CNS monocyte/macrophage trafficking (Brambilla, 2019). This evidence concerns the gene CCR5 and myeloid sarcoma.